CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Other disposition Director disposed of 571,741 shares (other)
- 4 Other acquisition Chief Legal Officer acquired 55,668 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 4,790 shares (other)
- 4 Other acquisition President and CEO acquired 86,476 shares (other)
- 4 Open-market sale 10% owner sold 525,550 shares at an average $24.19 ($12,713,502)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other disposition 10% owner disposed of 130,571 shares (other)
- 4 Open-market sale Chief Legal Officer sold 3,738 shares at $20.35 ($76,068)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition 10% owner disposed of 1,014,381 shares (other)
- 4 Open-market buy 10% owner bought 39,726 shares at an average $17.15 ($681,470)
- 4 Open-market buy 10% owner bought 7,803 shares at an average $19.87 ($155,072)
- 4 Open-market buy 10% owner bought 15,637 shares at an average $19.10 ($298,738)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 19 of 21 · 414 filings